Stobadine

Drug Profile

Stobadine

Latest Information Update: 28 Jan 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Nonindustrial source
  • Developer Nonindustrial source; Slovakofarma
  • Class Anti-ischaemics; Antiarrhythmics; Antipsychotics; Carbolines; Indoles; Ischaemic heart disorder therapies; Pyridones; Radioprotectives; Small molecules
  • Mechanism of Action Antioxidants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Discontinued Arrhythmias; Diabetic complications; Ischaemic heart disorders; Radiation injuries

Most Recent Events

  • 07 May 2003 Discontinued - Preclinical for Diabetic complications in Slovakia (unspecified route)
  • 25 Jun 2001 No-Development-Reported for Radiation injuries/Radioprotection in Slovakia (Unknown route)
  • 13 Jun 2001 No-Development-Reported for Diabetic complications in Slovakia (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top